Mouillet, Guillaume http://orcid.org/0000-0002-2288-7461
Falcoz, Antoine
Fritzsch, Joëlle
Almotlak, Hamadi
Jacoulet, Pascale
Pivot, Xavier
Villanueva, Cristian
Mansi, Laura
Kim, Stefano
Curtit, Elsa
Meneveau, Nathalie
Adotevi, Olivier
Jary, Marine
Eberst, Guillaume
Vienot, Angelique
Calcagno, Fabien
Pozet, Astrid
Djoumakh, Oumelkheir
Borg, Christophe
Westeel, Virginie
Anota, Amélie
Paget-Bailly, Sophie
Funding for this research was provided by:
Conseil régional de Bourgogne-Franche-Comté (APICHU 2016)
Article History
Accepted: 23 November 2020
First Online: 2 January 2021
Compliance with ethical standards
:
: G.M. received honoraria from Novartis, Pfizer, Roche, BMS, and Ipsen. A.A. received travel fees from Novartis and Roche. The other authors have stated that they have no conflicts of interest.
: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee (Est-II French Committee for Protection of Persons on January 25 2016 and the French national drug Agency (ANSM) on February 18 2016) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.